Jason Mellad
Director/Board Member at Revona Bio Ltd.
Jason Mellad active positions
| Companies | Position | Start | End |
|---|---|---|---|
Revona Bio Ltd.
 Revona Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Revona Bio Ltd. is a British biotechnology company that specializes in the development of RNA targeted drugs. The company was founded in 2022 by Anastasia Jane Callaghan and Charlotte Anne Henderson. | Director/Board Member | 17/10/2022 | - |
Octiocor Ltd.
 Octiocor Ltd. BiotechnologyHealth Technology Octiocor Ltd. is a British biotechnology company founded in 2022. The company is based in Cambridge, UK and engages in research and development of biotechnology. | Director/Board Member | 16/12/2022 | - |
Ephyra Ltd.
 Ephyra Ltd. BiotechnologyHealth Technology Ephyra Ltd. is a British biotechnology company founded in 2022 that engages in research and development. The company is based in Cambridge, UK. | Director/Board Member | 22/04/2022 | - |
Mote Research Ltd.
 Mote Research Ltd. Miscellaneous Commercial ServicesCommercial Services Mote Research Ltd. engages in research and experimental development on natural sciences and engineering. The private company is based in Cambridge, UK and was founded in 2015. | Director/Board Member | 15/10/2020 | - |
Tagomics Ltd.
 Tagomics Ltd. Miscellaneous Commercial ServicesCommercial Services Tagomics Ltd. is a British company founded in 2020 that works to transform disease diagnosis through comprehensive epigenomic profiling. The company is based in Birmingham, UK. The company's website is currently being finalized and will be online soon. The website uses cookies to improve user experience and analyze website usage. | Director/Board Member | 04/05/2021 | - |
Zygosity Ltd.
 Zygosity Ltd. Miscellaneous Commercial ServicesCommercial Services Zygosity Ltd. is a British biotechnology company founded in 2020 that engages in research and experimental development. The company is based in Cambridge, UK. | Director/Board Member | 19/01/2021 | - |
Career history of Jason Mellad
Statistics
International
| United Kingdom | 7 |
Operational
| Director/Board Member | 6 |
Sectoral
| Commercial Services | 5 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 6 |
|---|---|
Revona Bio Ltd.
Revona Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Revona Bio Ltd. is a British biotechnology company that specializes in the development of RNA targeted drugs. The company was founded in 2022 by Anastasia Jane Callaghan and Charlotte Anne Henderson. | Commercial Services |
Octiocor Ltd.
Octiocor Ltd. BiotechnologyHealth Technology Octiocor Ltd. is a British biotechnology company founded in 2022. The company is based in Cambridge, UK and engages in research and development of biotechnology. | Health Technology |
Ephyra Ltd.
Ephyra Ltd. BiotechnologyHealth Technology Ephyra Ltd. is a British biotechnology company founded in 2022 that engages in research and development. The company is based in Cambridge, UK. | Health Technology |
Mote Research Ltd.
Mote Research Ltd. Miscellaneous Commercial ServicesCommercial Services Mote Research Ltd. engages in research and experimental development on natural sciences and engineering. The private company is based in Cambridge, UK and was founded in 2015. | Commercial Services |
Tagomics Ltd.
Tagomics Ltd. Miscellaneous Commercial ServicesCommercial Services Tagomics Ltd. is a British company founded in 2020 that works to transform disease diagnosis through comprehensive epigenomic profiling. The company is based in Birmingham, UK. The company's website is currently being finalized and will be online soon. The website uses cookies to improve user experience and analyze website usage. | Commercial Services |
Zygosity Ltd.
Zygosity Ltd. Miscellaneous Commercial ServicesCommercial Services Zygosity Ltd. is a British biotechnology company founded in 2020 that engages in research and experimental development. The company is based in Cambridge, UK. | Commercial Services |
- Stock Market
- Insiders
- Jason Mellad
- Experience
